Manuel Effenberger

Manuel Effenberger is an experienced professional in the field of biotechnology, currently serving as the Manager of Product Development for Cell & Gene Therapy Reagents at Sartorius CellGenix GmbH since August 2023. Prior to this role, Effenberger held various positions at Juno Therapeutics, Inc. from June 2015 to August 2023, including Manager and Bioengineering Scientist, where responsibilities encompassed leading a pre-clinical CAR T cell manufacturing platform, resource planning, assay development, and regulatory interactions. Effenberger also contributed significantly as a Senior Scientist and Associate Scientist, focusing on process optimization and automation in cell manufacturing. Effenberger's academic background includes a PhD in Biotechnology from the Technical University of Munich, complemented by earlier degrees in Molecular Biotechnology. Work at the university involved the isolation and characterization of T cell receptors, along with a Master's thesis on tumor-specific T cell receptors and a Bachelor's thesis exploring dietary influences on colitis models.